VOLORIDGE INVESTMENT MANAGEMENT, LLC - BRIACELL THERAPEUTICS CORP ownership

BRIACELL THERAPEUTICS CORP's ticker is BCTX and the CUSIP is 10778Y302. A total of 26 filers reported holding BRIACELL THERAPEUTICS CORP in Q1 2022. The put-call ratio across all filers is 0.14 and the average weighting 0.4%.

Quarter-by-quarter ownership
VOLORIDGE INVESTMENT MANAGEMENT, LLC ownership history of BRIACELL THERAPEUTICS CORP
ValueSharesWeighting
Q1 2022$154,000
-90.9%
15,161
-92.5%
0.00%
-88.9%
Q4 2021$1,684,000
+32.5%
203,366
+29.6%
0.01%
+12.5%
Q3 2021$1,271,000156,9460.01%
Other shareholders
BRIACELL THERAPEUTICS CORP shareholders Q1 2022
NameSharesValueWeighting ↓
Lynwood Capital Management Inc. 1,583,878$10,168,49712.88%
Redmond Asset Management, LLC 137,689$883,9630.29%
K.J. Harrison & Partners Inc 34,640$216,8910.04%
WASATCH ADVISORS LP 612,088$3,929,6050.02%
Concord Wealth Partners 15,275$98,0660.02%
Caption Management, LLC 100,000$642,0000.01%
Summit Trail Advisors, LLC 35,000$224,7000.01%
NATIXIS 90,250$579,4050.01%
TD Waterhouse Canada Inc. 12,050$90,3460.00%
SIMPLEX TRADING, LLC 39,521$2530.00%
View complete list of BRIACELL THERAPEUTICS CORP shareholders